Twist Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2019 Annual Meeting of Stockholders held on July 23, 2019. Twist Bioscience Corporation (TWST) is an emerging growth company incorporated in Delaware, with its principal executive offices in San Francisco, CA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders representing approximately 61.76% of total outstanding shares (20,044,813 shares) were present in person or by proxy. Two proposals were voted upon:
- Proposal One (Election of Directors): Stockholders approved the election of three directors.
- Nelson Chan: 11,343,427 votes for; 4,474,417 votes withheld.
- Xiaoying Mai: 13,213,885 votes for; 2,603,959 votes withheld.
- Robert Ragusa: 13,199,624 votes for; 2,618,220 votes withheld.
- Proposal Two (Ratification of Accounting Firm): Stockholders ratified the appointment of PricewaterhouseCoopers LLP for the fiscal year ending September 30, 2020.
- Votes For: 19,897,780
- Votes Against: 8,624
- Abstentions: 138,409
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares eligible to be voted to confirm the 61.76% attendance rate.
- Review the full proxy statement for details on the nominees' qualifications and the rationale for the auditor ratification.
- Confirm the specific terms of engagement for PricewaterhouseCoopers LLP for the 2020 fiscal year.